Clinical Trial Update: BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of lapatinib with gemcitabine in metastatic pancreaticobiliary cancer was terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreaticobiliary Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Lapatinib (Lapatinib)

Snippet

Sponsor: Brown University | Conditions: Metastatic Pancreatic Cancer | Phase 1 | Status: TERMINATED | Results posted: 2014-05-19